|
|
| |
| |
Your access to vital information on lung cancer is now easier, with comprehensive coverage of this topic at your fingertips. ASCO has gathered and synthesized data on lung cancer from a multitude of key sources, including the Journal of Clinical Oncology and other ASCO publications, the Virtual Meeting, and more. Experience the ease of finding in-depth information on lung cancer topics, and visit often to remain current with timely updates.
|
|
| |
|
JCO Highlighted Lung Cancer Articles
|
Last Updated: October 20, 2009
|
 |
|
Japanese-US Common-Arm Analysis of Paclitaxel Plus Carboplatin in Advanced Non?Small-Cell Lung Cancer: A Model for Assessing Population-Related Pharmacogenomics
(JCO, July 2009)
|
|
|
Multicenter Phase II Trial of YM155, a Small-Molecule Suppressor of Survivin, in Patients With Advanced, Refractory, Non?Small-Cell Lung Cancer
(JCO, September 2009)
|
|
|
Phase II Study of Pemetrexed and Carboplatin Plus Bevacizumab With Maintenance Pemetrexed and Bevacizumab As First-Line Therapy for Nonsquamous Non?Small-Cell Lung Cancer
(JCO, July 2009)
|
|
|
Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer
(JCO, October 2009)
|
|
|
Duration of Chemotherapy for Advanced Non?Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Trials
(JCO, July 2009)
|
|
|
|
|
Medline Latest Lung Cancer Articles
|
Last Updated: November 1, 2009
|
|
|
Influence on the health of the partner affected by tumor disease in the wife or husband based on a population-based register study of cancer in Sweden.
(J Clin Oncol, 2009 Aug)
|
|
|
Phase I and biomarker study of ABT-869, a multiple receptor tyrosine kinase inhibitor, in patients with refractory solid malignancies.
(J Clin Oncol, 2009 Aug)
|
|
|
Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer.
(J Clin Oncol, 2009 Aug)
|
|
|
A phase I study with neratinib (HKI-272), an irreversible pan ErbB receptor tyrosine kinase inhibitor, in patients with solid tumors.
(Clin Cancer Res, 2009 Apr)
|
|
|
Antitumor activity of NK012 combined with cisplatin against small cell lung cancer and intestinal mucosal changes in tumor-bearing mouse after treatment.
(Clin Cancer Res, 2009 Jul)
|
|
|
|
|
Virtual Meeting
|
|
|
View lung cancer presentations from the 2008 ASCO Annual Meeting. In addition, search lung cancer presentations from previous meetings.
|
|
|
|
Abstracts
|
|
|
Search the 2008 melanoma abstracts as well as abstracts back through the 2000 Annual Meeting
|
|
|
|
Educational Book
|
|
|
Find lung cancer manuscripts grouped into areas of interest, or search the 2002-2009 Educational Books archive.
|
|
|
|
Cancer.Net
|
|
|
Find information and resources to support your patients living with lung cancer
|
|
|
|
|
|
|
|
 |
|
2010 ASCO Annual Meeting
McCormick Place – Chicago, IL
June 4 - 8, 2010
|
|
This online resource is supported by:
|
|
|
|
|
|
